Surgical Management of Bladder Carcinoma

Rafael Carrion, MD, John Seigne, MB


Cancer Control. 2002;9(4) 

In This Article

Appearance Suggesting a Superficial Tumor (Ta)

When the suspected diagnosis is superficial bladder cancer (based on the appearance of the tumor), consideration should be given to administering an immediate postoperative single intravesical dose of 40 mg of mitomycin C. In a randomized, controlled trial performed in Europe, a single postoperative intravesical administration of mitomycin C decreased the recurrence rate at 3 months from 55% to 40%.[6] Mitomycin C is presumed to act on the tumor cells that are released at the time of TUR by preventing their implantation and growth in deepithelialized areas created by the surgery.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.